Report #2829785

Received Mar 5, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 1 yrs
State: —
Recovered: Unknown
Vaccinated: Feb 26, 2025
Onset: Feb 26, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (ENGERIX-B)	GLAXOSMITHKLINE BIOLOGICALS	UNK	Y3NE2	—

Symptoms (1)

Expired product administered

Symptom narrative

Engerix-B administration after expiration date; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 20-month-old female patient who received HBV (Engerix B) (batch number Y3NE2, expiry date 23-FEB-2025) for prophylaxis. On 26-FEB-2025, the patient received Engerix B. On 26-FEB-2025, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: Engerix-B administration after expiration date). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 26-FEB-2025 The medical assistant asked if a patient should be revaccinated with Engerix-B after receiving an expired dose which led to expired vaccine used.